Medivir AB Alternatives & Competitors
12 companies similar to Medivir AB — Improving life for cancer patients through transformative drugs
Companies similar to Medivir AB
Ascelia Pharma AB
Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Stockholm und...
Malmo, Sweden
-logo. "Oncopeptides AB (publ)"){kind=logo}
Oncopeptides AB (publ)
Oncopeptides is a global biotech company focused on research & development of therapies fo...
Stockholm, Sweden
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Foster City, United State...
Semafore Pharmaceuticals
Pioneering the future of cancer treatment with innovative PI3K inhibitors.
Track all Medivir AB competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Coeptis Therapeutics
A biopharmaceutical company developing innovative cell therapy platforms for patients with...
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Israel
XSPRAY PHARMA AB (PUBL)
www.xspraypharma.com
Stockholm, Sweden
Asieris Pharmaceuticals
We strive for healthy and dignified lives!
United States
Sitka Biopharma
We're transforming chemotherapies to further benefit patients by enhancing efficacy & impr...
Canada
OnCusp Therapeutics
We Bring Oncology Innovation to Life
New York, United States
OnQuality Pharmaceuticals Ltd.
developing innovative drugs and drug delivery systems that improve the quality of life of...
Shanghai, China
Antengene
Treating Patients Beyond Borders.
Shanghai, China
About Medivir AB
Medivir AB is a Swedish company focused on biotechnology and pharmaceuticals. The company, founded in 1988, operates with the slogan "Improving life for cancer patients through transformative drugs". Medivir's primary goal is to develop innovative drugs, particularly targeting areas with high unmet medical needs, such...
Pharmaceuticals, Oncology, Drug Development, Biotech, Cancer Treatment, Research-based, Protease Inhibitors, Nucleotide Science, Clinical Development, Partnerships, Nasdaq Stockholm, Smart Chemotherapy, Specialty Care, Medical Innovation, Nordic Market
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Medivir AB and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Medivir AB on 14 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
